TDOC Teladoc Health Inc.

Pursuant to New York Stock Exchange Rule 303A.08, Employee Inducement Awards Are Granted by Teladoc

Teladoc, Inc. (NYSE: TDOC) announced today that it has granted non-qualified stock options to new employees as material inducements to their hiring. Stock options for the purchase of a total of eighty-eight thousand shares of Teladoc’s common stock, par value $0.001 per share (“Common Stock”), at a price per share of $22.30 were made to a total of fifteen persons. In addition, in conjunction with his recent hiring as executive vice president and chief revenue officer, Mr. Peter N. Nieves received a non-qualified stock option to purchase four hundred thousand shares of Common Stock at a price per share of $21.15.

Each of the options awarded vests as to twenty-five percent of the shares it covers on the first anniversary of its grant, with the remainder of the shares vesting ratably over thirty-six months thereafter. All of the options were granted outside the terms of Teladoc’s 2015 Incentive Award Plan in reliance on the employment inducement exemption under the NYSE’s Listed Company Manual Rule 303A.08. Pursuant to the requirements of that rule, Teladoc is issuing this press release.

About Teladoc

Teladoc, Inc. (NYSE:TDOC) is the nation’s leading provider of telehealth services and a pioneering force in bringing the virtual care visit into the mainstream of today’s health care ecosystem. Serving some 7,500 clients — including health plans, health systems, employers and other organizations — more than 17.5 million members can use phone, mobile devices and secure online video to connect within minutes to Teladoc’s network of more than 3,100 board-certified, state-licensed physicians and behavioral health specialists, 24/7. With national coverage, a robust, scalable platform and a Lewisville, TX-based member services center staffed by 400 employees, Teladoc offers the industry’s most comprehensive and complete telehealth solution including primary care, behavioral health care, dermatology, tobacco cessation and more. For additional information, please visit www.teladoc.com.

EN
17/03/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Teladoc Health Inc.

 PRESS RELEASE

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303...

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective March 1, 2026, in connection with commencing employment as Chief Growth Officer, U.S. Group Health, Daniel Conroy was granted an award of restricted stock units covering 57,034 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”), and an award of performance stock units covering a target of 5...

 PRESS RELEASE

Teladoc Health to Participate in Upcoming Investor Conference

Teladoc Health to Participate in Upcoming Investor Conference NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, will participate in the Barclays 28th Annual Global Healthcare Conference in Miami on March 10th, 2026, at 1:00 p.m. ET. A live audio webcast and replay of the presentation will be available at .  About Teladoc Health Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care pr...

 PRESS RELEASE

Teladoc Health Reports Fourth Quarter and Full Year 2025 Results

Teladoc Health Reports Fourth Quarter and Full Year 2025 Results NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended December 31, 2025 (“Fourth Quarter 2025”) and full year ended December 31, 2025 (“Full Year 2025”). Unless otherwise noted, percentage and other changes are relative to the three months ended December 31, 2024 (“Fourth Quarter 2024”) and full year ended December 31, 2024 (“Full Year 2024”). Highlights Fourth Quarter 2025 revenue of $642.3 million, flat...

 PRESS RELEASE

Teladoc Health Appoints Michael Smith, Experienced Insurance and Finan...

Teladoc Health Appoints Michael Smith, Experienced Insurance and Financial Services Executive, to Its Board of Directors NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Michael Smith to its board of directors. With more than three decades of leadership experience in financial management and strategic transformation, Mr. Smith brings a deep understanding of long-term business sustainability within highly regulated, global markets. He joins the board following the previously announced retirements ...

 PRESS RELEASE

Teladoc Health to Announce Fourth Quarter 2025 Financial Results

Teladoc Health to Announce Fourth Quarter 2025 Financial Results NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release fourth quarter 2025 results on Wednesday, February 25, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 330912. For international participants, please visit the...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch